| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26514fdcb7ecda81190de8371dbba9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f255f4e7672286414bee614d7c777e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bc16ff8b0a00f42578dba3da282f865 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C381-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76 |
| filingDate |
2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17f40793430c96a1e2cea777db15e9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b030cd0f47a96d39b5d1f210e84ebb51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c980e3e779f38445a8a34671a7c4e683 |
| publicationDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012028960-A1 |
| titleOfInvention |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| abstract |
A pharmaceutical composition comprising a drug substance consisting essentially of a pharmaceutically acceptable organic acid addition salt of an amine containing pharmaceutically active compound wherein the amine containing pharmaceutical active compound is selected from the group consisting of racemic or single isomer ritalinic acid or phenethylamine derivatives and the drug substance has a physical form selected from amorphous and polymorphic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022011350-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312684-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9839619-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017514848-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680043-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013236554-A1 |
| priorityDate |
2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |